How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,266 results for

Physical Medicine

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies

The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share October 13, 2009 ; 73 (15) Special Article Practice (...) Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology R. G. Miller , C. E. Jackson , E. J. Kasarskis , J. D. England , D. Forshew , W. Johnston , S. Kalra , J. S. Katz , H. Mitsumoto , J. Rosenfeld , C. Shoesmith , M. J. Strong , S. C. Woolley First published October 12, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181bc0141 R

2009 American Academy of Neurology

2. Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients LABORATORY MEDICINE PRACTICE GUIDELINES EDITED BY LORALIE J. LANGMAN AND PAUL J. JANNETTO Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Co-Sponsored byLABORATORY MEDICINE PRACTICE GUIDELINES Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Loralie J. Langman Committee Chair Department of Laboratory Medicine and Pathology Mayo Clinic (...) References 101 Table of ContentsLABORATORY MEDICINE PRACTICE GUIDELINES Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients 5 Executive Summary Introduction The American Association for Clinical Chemistry (AACC) Acad- emy, formerly the National Academy of Clinical Biochemistry (NACB), has developed a laboratory medicine practice guidelines (LMPG) for using laboratory tests to monitor drug therapy in pain management patients. The scope and purpose of this guideline

2018 American Academy of Pain Medicine

3. NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak

NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak 1 NCCP advice for Medical Professionals on the management of patients undergoing SACT Changes and additions from the last version are highlighted in yellow Version: 12.0 Department: NCCP Update date: 15/06/2020 CD19-013-003 Revision date: NCCP Systemic Therapy Programme NCCP advice for Medical Professionals (...) ://www.hse.ie/eng/services/list/5/cancer/patient/covid-19.html 2 NCCP advice for Medical Professionals on the management of patients undergoing SACT Changes and additions from the last version are highlighted in yellow Version: 12.0 Department: NCCP Update date: 15/06/2020 CD19-013-003 Revision date: NCCP Systemic Therapy Programme 3 Communication with patients receiving Systemic Anti-Cancer Therapy (SACT) (Chemotherapy) for the treatment of cancer 1. Communicate with patients and support their mental

2020 Health Service Executive (Ireland) - Clinical Guidelines

4. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (Full text)

. Diabetes Care 2009 32 647 9 Briesacher BA , Andrade SE , Fouayzi H , Chan KA . Medication adherence and use of generic drug therapies. Am J Manag Care 2009 15 450 6 Shrank WH , Hoang T , Ettner SL , Glassman PA , Nair K , DeLapp D . et al The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006 166 332 7 Taira DA , Wong KS , Frech-Tamas F , Chung RS . Copayment level and compliance with antihypertensive (...) Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians Opportunities From the Greater Use of Generic Medications | Annals of Internal Medicine | American College of Physicians '); } '); })(); Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org

2015 American College of Physicians PubMed abstract

5. Administration of medicinal products by non - medical personnel as part of Clinical Nuclear Medicine Procedures

(normally single dose or short-term administration). ? Recognition of, and appropriate action to take, in the case of suspected adverse reaction ? Communication with patients; o eliciting relevant information on potential contraindications, allergies and concurrent drug therapy o obtaining consent to administer the medicine Administration of Medicines 6 o advice to patient about potential delayed affects and actions required ? Intravenous injection and infusion ? Intermediate Life Support ? Relevant (...) , or CYP3A4 in human liver microsomes, indicating that it is unlikely to alter the pharmacokinetics of medicinal products metabolised by these cytochrome P450 enzymes. Contraindications ? Hypersensitivity to the active substance or to any of the excipients ? Second or third degree atrioventricular (AV) block or sinus node dysfunction, unless these patients have a functioning artificial pacemaker. ? Unstable angina that has not been stabilised with medical therapy. 42 ? Severe hypotension. ? Decompensated

2016 British Nuclear Medicine Society

6. Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association (Full text)

examples of leading medical schools that have integrated behavioral, nutrition, or physical activity sciences and counseling skills as part of their curricula. We mention postgraduate opportunities for lifestyle medicine training and provide links to detailed information about both MD and postgraduate programs. We also provide an overview of institutional and student program evaluations regarding lifestyle concepts and skills training included in US medical school curricula. Behavioral Sciences (...) and treat NCDs, as well as how to improve their communication skills with patients regarding lifestyle medicine counseling. Postgraduate Programs and Continuous Medical Education In addition to the critical role of medical schools in teaching the fundamentals of behavioral sciences, tobacco use, nutrition, and physical activity to future physicians, opportunities for postgraduate training during residencies and fellowships are essential, as is continuing medical education. We believe that all primary

2016 American Heart Association PubMed abstract

7. Medical Emergencies - medical emergencies in adults (overview)

haemorrhage ? where appropriate, consider cannulation for drug administration. Fluid Therapy NOTE: Special guidance applies in pregnant women (refer to speci?c guidelines in the obstetrics and gynaecological section). Current research shows little evidence to support the routine use of IV ?uids in adult acute blood loss. In circumstances such as penetrating chest and abdominal trauma, survival worsens with the routine use of IV ?uids. 2 Fluids may raise the blood pressure, cool the blood and dilute (...) ? social history. Combined with a good physical examination, this format of history taking should ensure that you correctly identify those patients who are time critical, urgent or routine. The history taken must be fully documented. In many cases, a well-taken history will point to the diagnosis. The presence of “Medic Alert” type jewellery (bracelets or necklets) can provide information on the patient’s pre-existing health risk that may be relevant to the current medical emergency. SECONDARY SURVEY

2007 Joint Royal Colleges Ambulance Liaison Committee

8. Physical health and drug safety in individuals with schizophrenia (Full text)

Physical health and drug safety in individuals with schizophrenia While antipsychotic medications are the mainstay of therapy for individuals with schizophrenia and psychotic disorders, their use is associated with adverse effects on physical health that require the attention and care of prescribers.We used the ADAPTE process to adapt existing guideline recommendations from the National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN (...) interventions are recommended to mitigate antipsychotic-induced weight gain. Prescribers should follow Canadian guidelines on the treatment of obesity, dyslipidemia, and diabetes. Recommendations on antipsychotic drug choice are made for users particularly concerned about extrapyramidal symptoms.Careful monitoring and attention by prescribers may mitigate adverse effects associated with antipsychotic medications.

2017 CPG Infobase PubMed abstract

9. Appropriate Use of Drug Testing in Clinical Addiction Medicine

Special External Reviewer Michael Miller, MD, DFASAM, FAPA IRETATeam Members (in alphabetical order) Peter Cohen, MD, Medical Advisor Leila Giles, BS Matthew Hurford, MD, Expert Panel Moderator Piper Lincoln, MS Dawn Lindsay, PhD Peter Luongo, PhD Jessica Williams, MPH Disclosure information for the ASAM Expert Panel Mem- bers and Quality Improvement Council is available in Appendix 6. INTRODUCTION Purpose The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine (...) should be utilized effectively in treatment. ASAM has produced 2 key documents related to drug testing: ‘‘Public Policy Statement on Drug Testing as a Endorsed by the American College of Medical Toxicology. Adopted by the ASAM Board of Directors April 5, 2017 1 CONSENSUS STATEMENTCopyright © 2017 American Society of Addiction Medicine. Unauthorized reproduction of this article is prohibited. Component of Addiction Treatment and Monitoring Pro- grams and in other Clinical Settings’’ and ‘‘Drug

2017 American Society of Addiction Medicine

10. Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia

Grading of Recommendations Assessment, Development and Evaluation GDG Guideline Development Group GDP Global Domestic Product MCI Mild Cognitive Impairment MHBC Ministry of Health British Columbia MHRA Medicines and Healthcare products Regulatory Agency NCEC National Clinical Effectiveness Committee NHMRC National Health and Medical Research Council NHS National Health Service NICE National Institute for Health and Care Excellence NPI Neuropsychiatric Inventory PBS Pharmaceutical Benefit Scheme PDD (...) . However, most evidence is based on common dementia types, particularly Alzheimer’s dementia; this needs to be borne in mind by the user when applying the evidence to other dementia types. Clinicians’ attention is also drawn to the fact that many psychotropic medications are used “off label” for people with dementia, particularly antipsychotic medication. While this is not prohibited by medicine regulations, it does require particular caution by the prescriber. This National Clinical Guideline

2019 National Clinical Guidelines (Ireland)

11. A guide to understanding the implications of the Ionising Radiation (Medical Exposure) Regulations in diagnostic and interventional radiology

and definitions 7 The employer 7 The employer’s responsibilities 7 The employer’s responsibilities for training 8 The referrer 9 Information required for a referral 9 Electronic requesting 10 The practitioner 10 Detriments to be considered in justifying an exposure 12 The operator 12 Professional responsibility 13 Authorisation 13 The role of the medical physics expert 13 The role of individuals who are not registered healthcare professionals such as radiography assistant practitioners in practical aspects (...) Royal College of Radiologists (RCR), Society and College of Radiographers (SCoR) and Institute of Physics and Engineering in Medicine (IPEM) document was published offering guidance on IR(ME)R for the radiotherapy community. 2 This was well received and became a respected guidance document. It is now apparent that practical guidance on the implications of IR(ME)R would benefit the radiology and interventional imaging community. The RCR, the SCoR, and the BIR (British Institute of Radiology) have

2015 Royal College of Radiologists

12. Interagency Guideline for Prescribing Opioids for Pain Agency Medical Directors' Group (AMDG)

for Chronic Non- cancer Pain Opioids in the Chronic Phase (>12 weeks after an episode of pain or surgery) Managing chronic pain and providing appropriate opioid therapy is a challenging aspect of both primary care and specialty care practices. This is why it is critical for providers to be very conscious of the risks and intentional about the treatment plan when prescribing these drugs. The key to effective COAT is sustained improvement in physical function and pain with frequent monitoring to adjust (...) drug therapy or comorbid medical conditions) Patient has experienced a severe adverse outcome or overdose event Patient has a substance use disorder (except tobacco) Use of opioids is not in compliance with DOH’s pain management rules or consistent with the AMDG Guideline Patient exhibits aberrant behaviors (Table 9) Clinical Recommendations 1. Help the patient understand that chronic pain is a complex disease, and opioids alone cannot adequately address all of the patient’s pain-related needs

2015 Washington State Department of Labor and Industries

13. Alternatives to Regular Medication Normally Given via a Syringe Pump When this is Not Available

or suspected to have an infectious agent. As the situation changes, there may be changing availability of drugs. We aim to keep these guidelines updated in view of this. Management Anticipatory prescribing The aim of anticipatory prescribing is to ensure that patients with advancing illness and uncontrolled symptoms have timely access to medications to improve their physical comfort. Guidance for this is available in the Scottish Palliative Care Guidelines. The following guidelines are for use when usual (...) be a reasonable alternative. Some medicines are available as buccal preparations – moistening a dry mouth helps absorption. Some injectable preparations can be administered by the buccal or sublingual route. Drugs given by the sublingual or buccal route can also be dispersed in water and administered down an NG tube where this is in place. Medication Pain/Breathlessness/Cough/Pyrexia Medicine Route Dose Administration/ Comments Paracetamol suppositories 500mg and 1g Rectal SHORT ACTING 500mg to 1g every 4-6

2020 Scottish Palliative Care Guidelines

14. Australian Institute of Sport and Australian Medical Association position statement on concussion in sport

is suspected, the athlete must be immediately removed from sport and not be allowed to return to activity until they have been assessed by a medical practitioner. “If in doubt, sit them out.” A diagnosis of concussion requires immediate physical and cognitive rest, followed by a structured, graduated return to physical activity. Children require a longer period of recovery from concussion. Algorithms are provided for use by medical and non-medically trained stakeholders in the recognition and management (...) Australian Institute of Sport and Australian Medical Association position statement on concussion in sport Australian Institute of Sport and Australian Medical Association position statement on concussion in sport | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect

2017 MJA Clinical Guidelines

15. Principles of Pediatric Patient Safety: Reducing Harm Due to Medical Care

the standardization of concentrations in compounded medications; developing, spreading, and advocating for pediatric-specific health care information technology for drug delivery; educating providers on methods to reduce medication errors, including medication reconciliation; ensuring that providers maintain access to and proficiency in the use of a comprehensive and current pharmaceutical knowledge base; and creating policies that advocate for safe medication delivery to children in all health care settings (...) . Principles of Pediatric Patient Safety: Reducing Harm Due to Medical Care Brigitta U. Mueller , Daniel Robert Neuspiel , Erin R. Stucky Fisher , COUNCIL ON QUALITY IMPROVEMENT AND PATIENT SAFETY, COMMITTEE ON HOSPITAL CARE Abstract Pediatricians render care in an increasingly complex environment, which results in multiple opportunities to cause unintended harm. National awareness of patient safety risks has grown since the National Academy of Medicine (formerly the Institute of Medicine) published its

2019 American Academy of Pediatrics

16. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas

for bilateral A VS to distinguish APA from PAH and referred to a medical center familiar with this procedure. Patients too infirm for surgical management, those with a limited life expectancy, and those comfortable with medical therapy utilizing mineralocorticoid receptor blockers need no further evaluation (65 [EL 4], 71 [EL 2], 72 [EL 2], 75 [EL 4], 76 [EL 4]). Patients should discon- tinue the use of spironolactone for 6 weeks and eplerenone for 4 weeks before A VS. The success of A VS is very much (...) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas ENDOCRINE PRACTICE Vol 15 (Suppl 1) July/August 2009 1 AACE/AAES Guidelines © 2009 AACE. AmERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS AND AmERICAN ASSOCIATION Of ENDOCRINE SuRgEONS mEDICAl guIDElINES fOR ThE mANAgEmENT Of ADRENAl INCIDENTAlOmAS Martha A. Zeiger, MD, FACS, FACE; Geoffrey B. Thompson, MD, FACS, FACE; Quan-Yang Duh

2009 American Association of Clinical Endocrinologists

17. Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-deficient Adults and Transition Patients

the role of GH in adulthood, in particular the effects and safety of GH replacement in GH-deficient adults (10 [EL 2], 11 [EL 3]). In the United States, recombinant GH was approved by the Food and Drug Administration (FDA) in 1996 for use as replacement therapy in GH-deficient adults. Although treatment appears to be safe overall in the first decade of use in adults, certain parameters still necessitate long-term surveillance, such as whether GH replacement aimed at normalizing serum insulin-like (...) , such as in cardiovascular risk markers, BMD, body com- position, or physical activity tolerance, then GH treatment should be continued indefinitely. If there are neither sub- jective nor objective benefits of treatment, some clinicians and patients might decide to consider stopping GH treat- ment altogether. 13. SAFETY ISSUES WITH GH REPLACEMENT THERAPY 13.1. Diabetes mellitus Although there is no evidence to date that long-term GH replacement therapy increases the risk of diabetes mel- litus in adults (145 [EL 4

2009 American Association of Clinical Endocrinologists

18. AACE/ACE/AME Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules

Professor of Medicine, Mayo Clinic College of Medicine, Past President, American Association of Clinical Endocrinologists, Past President, American Thyroid Association; 2 Director, Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Via San Francesco 50, 00041, Albano, Rome (Italy); 3 Endocrine Division, Harvard Vanguard Medical Associates, Boston, Massachusetts, Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 4 Endocrinology Associates, PA (...) ” method. Each topic covered by the guidelines was translated to a related question. Accordingly, the bibliographic research was con- ducted by selecting studies able to yield a methodologi- cally reliable answer to each question. The first step was to select pertinent published reports. The U.S. National Library of Medicine Medical Subject Headings (MeSH) database was used as a terminologic filter. Appropriate MeSH terms were identified, and care was taken to select them on a sensitive rather than

2016 American Association of Clinical Endocrinologists

19. Medical eligibility criteria for contraceptive use

for meta-analyses was provided by Rochelle Fu. Technical and copy-editing were provided by Jura Editorial Services (jura-eds.com) and Green Ink, United Kingdom (greenink.co.uk). Funding The development of this guideline was financially supported by the National Institutes of Health (NIH) and United States Agency for International Development (USAID).Medical eligibility criteria for contraceptive use - Executive summary | 3 Abbreviations ART antiretroviral therapy ARV antiretroviral (medication) ß-hCG (...) device CVR combined contraceptive vaginal ring CYP3A4 cytochrome P450 3A4 enzyme DMPA depot medroxyprogesterone acetate DMPA-IM depot medroxyprogesterone acetate – intramuscular DMPA-SC depot medroxyprogesterone acetate – subcutaneous DVT deep vein thrombosis ECP emergency contraceptive pill EE ethinyl estradiol E-IUD emergency intrauterine device EMA European Medicines Agency ETG etonogestrel FAB fertility awareness-based methods FDA United States Food and Drug Administration GDG Guideline

2015 World Health Organisation Guidelines

20. Policy on Medically-Necessary Care

and pro-vision of individual and community-based health care programs to achieve comprehensive health care. 2. Establishment of a dental home for all children by 12 months of age in order to institute an individualized preventive oral health program based upon each patient’s unique caries risk assessment. 3. Healthcare providers who diagnose oral disease to either provide therapy or refer the patient to a primary care dentist or dental/medical specialist as dictated by the nature and complexity (...) 2000;22(1):27-32. 67. Prabhu NT, Nunn JH, Evans DJ. A comparison of costs in providing dental care for special needs patients under sedation or general anesthesia in the North East of England. Prim Dent Care 2006;13(4):125-8. 68. Institute of Medicine Committee on Medicare Coverage Extensions. Medically necessary dental services. In; Field MJ, Lawrence RL, Zwanziger L, eds. Extending Medicare Coverage for Preventive and Other Services. Washington (DC): National Academies Press (US); 2000. Available

2019 American Academy of Pediatric Dentistry

Guidelines

Guidelines – filter by country